“As we wrap up 2023, a most transformative year for TrialX, we optimistically look towards 2024 with great anticipation and see a future where patient recruitment is not just a process, but a seamless journey. Boasting over 40K clinical trial listings and supporting over 444 trials for Top Pharma, leading academic institutions and patient advocacy groups, TrialX stands at the forefront of managing the clinical trial recruitment process. Our one of a kind, global trial listings bridge diverse communities and open the doors to research for more people than ever before. Study teams are also taking advantage of our eCOA platform to run their virtual/hybrid trials, an easy-to-use, budget friendly solution for sites and participants. Now, capturing clinical trial data and gathering insights has never been easier. Even astronauts on commercial space missions are capturing clinical data using TrialX. Our mission (no pun intended) is to facilitate one billion health research contributions. Happy Holidays, and Cheers to 2024!”
Paul Donnelly, CSO, TrialX Inc.
Wishing you Happy Holidays and a spectacular new year 2024!
🎁 PRODUCT HIGHLIGHTS 2023
- Developed first-in-class multi-country clinical trials listing websites to reach diverse audiences
- Supported Top-3 Pharma pre-screening workflow to streamline entire portfolio
- Developed multi-protocol pre-screeners for complex workflows to maximize recruitment efforts
- Optimized analytics dashboards to promote ROI
- Created the first repository for all health and wearable data capture on commercial space missions
- Launched Pyelonephritis Tracker app for a major sponsor
- Enhanced site data capture using virtual visits
- Advanced analytics for monitors, CROs, sponsors and sites
- Effects of Space Missions on Human Health with Dr. Mathias Basner, Penn Medicine – 13K views
- Multiple Sclerosis Care Through Precision Medicine with Dr. Amit Bar-Or, Penn Medicine – 10K views
- Beyond CAR-T: Re-engineering Cells into Life-saving Therapies with Dr. Lawrence Fong, UCSF Cancer – 13K views
📰 PRESS RELEASE
The Translational Research Institute for Space Health (TRISH) selects TrialX to develop systems to improve healthcare delivery and data management for spaceflight participants and researchers. We are privileged and excited to be a part of this groundbreaking collaboration. TRISH, in partnership with MIT and Caltech, is spearheading transformative projects to enhance healthcare delivery and data management for spaceflight participants and researchers. These projects hold the potential to reshape the future of space health as well as transform healthcare on earth, and we couldn’t be more thrilled to contribute to this mission! Read More. Photo credit: TRISH
Cutting-edge technologies driving the future of life science research were showcased at the CNS summit 2023, with site burden being cited as a consistent challenge in the clinical trial industry. Our CSO, Paul Donnelly shared how TrialX is driving innovation in Remote Data Collection and Enterprise Recruitment Solutions. Learn more.
At DTx east we networked with leaders in digital therapeutics and digital health solutions space and shared about our innovative solutions connecting the dots in clinical trials & remote data collection. Learn More.
From designing digital inclusive protocols to creating efficiencies along the way, at the Digital Health Innovation Summit in San Francisco, the theme revolved around improving health outcomes, faster drug development and personalized care. More and more companies are making digital a priority realizing its capability in helping streamline clinical trials processes, reduce in-clinic time spent, speed up recruitment, reduce prescreen failures and associated costs. We shared how TrialX is enabling decentralized clinical research here on earth and in space.
We were on the panel with the Translational Research Institute for Space Health (TRISH) and other space medicine scientists at the Aerospace Medical Association’s 93rd Annual Scientific Meeting. Our Co-founder & CEO Dr. Sharib Khan presented EXPAND DB – the database built for TRISH – the first database of human health & environmental data from commercial space flights, designed to support a variety of data types across a multitude of individual research studies. The database currently houses data from subjects across five space missions – Inspiration 4, MS-20, Axiom-1, Axiom-2 and Polaris Dawn and equips space researchers to reuse and integrate research data across different research studies unlocking innovative actionable insights. Learn more.
We were in Barcelona at the 13th Annual Outsourcing in Clinical Trials Europe conference, a gathering of industry leaders providing practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials.
Decentralized clinical trials technology, diversity in clinical trials, real world data and real world evidence dominated the discussions at SCOPE 2023. Coming off last year where there was a fraction of attendance compared to 2023, many including TrialX, found it successful on many fronts. Read more.
Our Co-founder & CEO was on the panel at the TRISH Orbit Rendezvous along with Dr. Eric Bershad and Dr. Harsha V Doddapaneni of Baylor College of Medicine and Jimmy Wu and Dr. Rihana Bokhari of Translational Research Institute for Space Health. The panel discussed the EXPAND database and future data access for researchers as more data is collected from commercial spaceflight participants. Listen here.
Dr. Chintan Patel, our Co-founder and CTO was invited to speak at the Future Space Economy Webcast, a discussion featuring representatives from space companies that are working with medical research partners to bring innovative healthcare to the world through future space technologies. Learn more.
🎓 MILESTONE ANNOUNCEMENTS
The Axiom Mission 3 launches Jan 9, 2024! In partnership with TRISH (The Translational Research Institute for Space Health) we are excited to support yet another space mission through the EXPAND mobile App that collects and stores pre-flight, in-flight and post-flight health data from commercial astronauts during space Missions. TRISH will conduct a suite of human health and performance research projects during this first all-European commercial astronaut mission to the ISS. Stay tuned for more! Photo credit: TRISH
After an intense 60+ hours deployment, we successfully went live with 1 of the top 3 pharmaceutical companies globally. This marks our biggest go-live event this year with more coming to close out 2023! Learn more about our enterprise patient recruitment management solution.
We are proud to support RECOVER (Researching COVID to Enhance Recovery), a nationwide initiative dedicated to understanding, treating, and preventing Long COVID. Our award winning patient recruitment management system is helping study locations streamline patient recruitment and retention. The initiative aims to recruit more than 30,000 participants.
✌ TEAM UPDATES
TrialX Success Story: We were invited to talk about TrialX’s success story and the impact of innovation at the Orion Summit 2023. Listen to this exhilarating narrative of how TrialX came to be what it is today.
Setting up in the Big Apple: TrialX Co-founder & CTO Dr. Chintan Patel, was invited to share the NYC experience of starting a healthcare Informatics company at an information session titled “New York City from Within” organized by the Consulate of Belgium. In this session American startups/scale-ups based in New York City share their inspiring stories about setting up in the Big Apple and growing in the USA from here. Learn more.
TrialX turned 15! We celebrated in the “Land of the Free”! As the candles flickered out, we raised our glasses in a toast to the future of healthcare innovation, with a wish empowering TrialX with the strength it needs to support clinical research here on earth and in space. Cheers to a journey filled with accomplishments and advancements! Read More.
🌏 AROUND THE WEB
- 🚀 Ax-3 crew stands mission ready
- 🍅 Saucy story of two rogue tomatoes!
- 🔬 A new era in clinical trials
- 👽Is humanity prepared for contact with intelligent aliens?